Targeting components of the alternative NHEJ pathway sensitizes KRAS mutant leukemic cells to chemotherapy. [electronic resource]
Producer: 20140604Description: 2355-66 p. digitalISSN:- 1528-0020
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Comet Assay
- DNA Breaks, Double-Stranded
- DNA Repair -- drug effects
- Disease Models, Animal
- Humans
- Immunohistochemistry
- Mice
- Mice, Inbred C57BL
- Mice, Transgenic
- Mutation
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Proto-Oncogene Proteins p21(ras) -- genetics
- Transduction, Genetic
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.